03/29/2024 5:11 AM | Cyteir Therapeutics (Filer)
| Form 15-12G | |
03/25/2024 10:05 AM | Cyteir Therapeutics (Issuer) Leonard Braden Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:16 PM | Cyteir Therapeutics (Filer)
| Form S-8 POS | |
03/21/2024 3:17 PM | Cyteir Therapeutics (Filer)
| Form S-8 POS | |
03/21/2024 3:17 PM | Cyteir Therapeutics (Filer)
| Form S-8 POS | |
03/20/2024 3:55 PM | Cyteir Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 6:21 AM | Cyteir Therapeutics (Filer)
| Form POS AM | |
|
03/18/2024 6:23 AM | Cyteir Therapeutics (Filer)
| Form POS AM | |
03/18/2024 6:24 AM | Cyteir Therapeutics (Filer)
| Form POS AM | |
03/18/2024 5:07 AM | Cyteir Therapeutics (Filer)
| Form 25 Notification of the removal from listing and registration of matured, redeemed or retired securities | |
03/13/2024 11:15 PM | Cyteir Therapeutics (Filer)
| Form EFFECT | |
03/12/2024 3:30 PM | Cyteir Therapeutics (Filer)
| Form POS AM | |
03/12/2024 3:16 PM | Cyteir Therapeutics (Subject) GAMCO INVESTORS, INC. ET AL (Filed by)
| Form SC 13D/A | |
03/07/2024 3:31 PM | Cyteir Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 5:10 PM | Cyteir Therapeutics (Issuer) RENSCHLER MARKUS MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 5:11 PM | Cyteir Therapeutics (Issuer) Gaiero David G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:36 PM | Cyteir Therapeutics (Subject) Lightstone Ventures II, L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024 6:14 PM | Avidity Partners Management LP (Filed by) Cyteir Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 3:28 PM | Cyteir Therapeutics (Subject) GAMCO INVESTORS, INC. ET AL (Filed by)
| Form SC 13D/A | |
02/08/2024 3:11 PM | Cyteir Therapeutics (Issuer) Zakrzewski Joseph S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2024 12:40 PM | BML Investment Partners, L.P. (Filed by) Cyteir Therapeutics (Subject)
| Form SC 13G/A | |
01/19/2024 8:30 AM | Cyteir Therapeutics (Subject) HEDGEHOG CAPITAL LLC (Filed by)
| Form SC 13G/A | |
11/22/2023 12:47 PM | Cyteir Therapeutics (Issuer) Gaiero David G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 12:48 PM | Cyteir Therapeutics (Issuer) RENSCHLER MARKUS MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 4:00 PM | Cyteir Therapeutics (Subject) HEDGEHOG CAPITAL LLC (Filed by)
| Form SC 13G | |
10/19/2023 3:07 PM | Cyteir Therapeutics (Subject) GAMCO INVESTORS, INC. ET AL (Filed by)
| Form SC 13D | |
10/12/2023 3:14 PM | Cyteir Therapeutics (Filer)
| Form DEFM14A | |
10/12/2023 6:51 AM | Cyteir Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/12/2023 6:52 AM | Cyteir Therapeutics (Filer)
| Form DEFA14A | |
10/02/2023 3:44 PM | Cyteir Therapeutics (Filer)
| Form PREM14A | |
07/20/2023 7:01 PM | Cyteir Therapeutics (Issuer) Novo Holdings A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 7:27 PM | Cyteir Therapeutics (Issuer) Novo Holdings A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/14/2023 3:56 PM | Cyteir Therapeutics (Subject) Novo Holdings A/S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023 9:20 AM | Cyteir Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
07/03/2023 5:29 PM | Cyteir Therapeutics (Issuer) Novo Holdings A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 4:29 PM | Cyteir Therapeutics (Subject) Secrist John Paul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023 9:37 AM | Cyteir Therapeutics (Filer)
| Form DEFA14A | |
06/30/2023 9:22 AM | Cyteir Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2023 8:35 PM | Cyteir Therapeutics (Issuer) Novo Holdings A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 5:02 PM | Cyteir Therapeutics (Subject) Secrist John Paul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023 6:17 PM | Cyteir Therapeutics (Issuer) Novo Holdings A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
06/20/2023 4:53 PM | Cyteir Therapeutics (Issuer) Novo Holdings A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 7:18 PM | Cyteir Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 7:18 PM | Cyteir Therapeutics (Issuer) Novo Holdings A/S (Reporting) Novo Holdings A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 7:14 PM | Cyteir Therapeutics (Subject) Novo Holdings A/S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023 7:00 AM | Cyteir Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2023 3:27 PM | Cyteir Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |